EPS Diluted (TTM) Chart

Historical EPS Diluted (TTM) Data

View and export this data back to 2015. Start Trial.
Date Value
June 30, 2026 -16.47
March 31, 2026 -37.67
December 31, 2025 -32.91
September 30, 2025 -26.94
June 30, 2025 -16.69
March 31, 2025 4.192
December 31, 2024 1.234
September 30, 2024 -4.308
June 30, 2024 -8.127
March 31, 2024 -9.035
December 31, 2023 -9.196
September 30, 2023 -10.52
June 30, 2023 -12.52
March 31, 2023 -14.83
December 31, 2022 -100.35
September 30, 2022 -100.09
June 30, 2022 -97.93
March 31, 2022 -95.62
December 31, 2021 -9.250
September 30, 2021 -8.806
June 30, 2021 -8.316
March 31, 2021 -8.102
December 31, 2020 -11.19
Date Value
September 30, 2020 -11.48
June 30, 2020 -11.28
March 31, 2020 -11.38
December 31, 2019 -8.353
September 30, 2019 -9.313
June 30, 2019 -9.661
March 31, 2019 -11.66
December 31, 2018 -12.77
September 30, 2018 -8.637
June 30, 2018 -12.77
March 31, 2018 -43.92
December 31, 2017 -45.62
September 30, 2017 -47.89
June 30, 2017 -43.99
March 31, 2017 -10.33
December 31, 2016 -6.317
September 30, 2016 -5.191
June 30, 2016 -3.692
March 31, 2016 -2.612
December 31, 2015 -1.990
September 30, 2015 -1.166
June 30, 2015 -0.5654
March 31, 2015 -0.1632

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Abbott Laboratories 3.094
AngioDynamics, Inc. -0.7897
Alphatec Holdings, Inc. -0.7164
AtriCure, Inc. 0.2164
Baxter International, Inc. -1.928